Levocetirizine
- Atc Codes:R06AE09
- CAS Codes:130018-87-0
- PHARMGKB ID:130018-87-0
Table of contents
- Brand Names
- Chemistry
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Pregnancy and Lactation Implications
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Genes that may be involved
- Drug Interactions
- Nutrition/Nutraceutical Interactions
- Dosage
- Pharmacokinetics and Pharmacodynamics
- Special Considerations
Brand Names
Europe
Austria: Histalos, Lecisyn, Lecivriens, Levocetilerg, Levocetirizin, Xyzall; Belgium: Levocetirizine, Xyzall; Bulgaria: Xyzal; Cyprus: Xyzall; Czech Republic: Cezera, Lavaz, Lecivriens, Levocetirizin, Levozine, Sintir, Volnostin, Xyzal, Zenaro; Denmark: Levazyr, Levocetirizin, Xyzal; Estonia: Levocetirizine, Xyzal; Finland: Lecisyne, Lecivriens, Levazyr, Levocetilerg, Levocetirizin, Levocetirizine, Nocedan, Xyzal; France: Levocetirizine, Xyzal; Germany: Levocetirizin, Sopras, Xusal, Xyzal; Greece: Xozal; Hungary: Xyzal; Ireland: Levocetirizine, Muntel, Rinozal, Xyzall; Italy: Xyzall; Latvia: Levocetirizine, Xyzal, Zenaro; Lithuania: Levocetirizine, Xyzal; Luxembourg: Xyzall; Malta: Xyzal; Netherlands: Levocetirizine, Xyzal; Poland: Cezera, Xyzal; Portugal: Levocetirizina, Levrix, Xyzal; Romania: Cezera, Lerazin, Levocetirizina, Xyzal; Slovakia: Cezera, Levocetirizin, Levocetirizine, Xyzal, Zenaro; Slovenia: Xyzal; Spain: Levocetirizina, Muntel, Xazal; Sweden: Xyzall; UK: Xyzal.
North America
USA: Xyzal.
Latin America
Argentina: Analerg, Cetimer L, Levomine, Supraler; Brazil: Zyxem; Mexico: Xuzal, Zyxem.
Drug combinations
Chemistry
Levocetirizine Dihydrochloride: C~21~H~25~ClN~2~O~3~ 2HCl. Mw: 461.80. (1) Acetic acid, [2-[4-[(R)-(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-, dihydrochloride; (2)(2-{4-[(R)-(4-Chlorophenyl)phenylmethyl]piperazin-1-yl}ethoxy)acetic acid dihydrochloride. CAS-130018-87-0 (2007).
Pharmacologic Category
Second Generation Antihistamines; Histamine H~1~ Antagonist. (ATC-Code: R06AE09).
Mechanism of action
Antihistamine which selectively competes with histamine for H~1~-receptor sites on effector cells in GI tract, blood vessels, and respiratory tract.
Therapeutic use
Relief of symptoms of perennial and seasonal allergic rhinitis. Treatment of skin manifestations (uncomplicated) of chronic idiopathic urticaria.
Pregnancy and lactiation implications
Levocetirizine not teratogenic in animal studies. Use during pregnancy only if clearly needed. Use not recommended while breast-feeding.
Unlabeled use
Contraindications
Hypersensitivity to levocetirizine, cetirizine, or any component of the formulation. End-stage renal disease. Hemodialysis. Children 6-11 years of age with renal impairment.
Warnings and precautions
May cause CNS depression. Use with caution in adults with mild-to-moderate renal impairment (this drug excreted primarily by kidneys). Use contraindicated in end-stage renal disease (CrCl <10 mL/minute), patients undergoing hemodialysis, and in children 6-11 years of age with renal impairment. Use with caution in the elderly. Not FDA approved for use in children <6 years of age.